Nombre del producto |
disulfato de butirosina |
Sinónimos |
Sulfato de butosina anhidro [USAN]; Sulfato de butosina; Sulfato de ambutirosina; Sulfato de butosina anhidro; Sulfato de butirosina; Butirosina sulfato anhidro; Butirosina, sulfato (sal); CL 642; D-estreptamina, mezcla dihidratada de O-2,6-diamino-2,6-didesoxi-alfa-D-glucopiranosil-(1-4)-O-(beta-D-xilofuranosil-(1-5))-N(sup 1)-(4-amino-2-hidroxi-1-oxobutil)-2-desoxi-, (S)-, sulfato (1:2) (sal) con O-2,6-diamino-2,6-dideoxi-alfa-D-glucopiranosilo-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-((S)-4-amino-2-hidroxi-1-oxobutil)-2-desoxi-D-estreptamina sulfato (1:2) (sal) anhidro; Mezcla dihidratada de O-2,6-diamino-2,6-didesoxi-alfa-D-glucopiranosil-(1-4)-O-(beta-D-xilofuranosil-(1-5))-N(sup 1)-(4-amino-L-2-hidroxibutiril)-2-desoxi-D-estreptamina sulfato (1:2) (sal) con O-2,6-diamino-2,6-didesoxi-alfa-D-glucopiranosil-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hidroxibutiril)-2-desoxi-D-estreptamina sulfato (1:2) (sal) anhidro; 4-amino-N-{(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-didesoxi-alfa-D-glucopiranosil)oxi]-2-hidroxi-3-[(3xi)-beta-D-eritro-pentofuranosiloxi]ciclohexilo}-2-hidroxibutanamida sulfato hidrato (1:2:2); 4-amino-N-[(2R,3R)-5-amino-4-[(2,6-diamino-2,6-didesoxi-L-eritro-hexopiranosil)oxi]-2-hidroxi-3-(D-lixofuranosiloxi)ciclohexilo]-2-hidroxibutanamida disulfato (sal) |
Nombre en inglés |
butirosin disulfate;Butirosin sulfate anhydrous [USAN]; Butirosin sulfate; Ambutyrosin sulfate; Butirosin sulfate anhydrous; Butirosin sulphate; Butirosin sulphate anhydrous; Butirosin, sulfate (salt); CL 642; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-((S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; O-2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; 4-amino-N-{(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-3-[(3xi)-beta-D-erythro-pentofuranosyloxy]cyclohexyl}-2-hydroxybutanamide sulfate hydrate (1:2:2); 4-amino-N-[(2R,3R)-5-amino-4-[(2,6-diamino-2,6-dideoxy-L-erythro-hexopyranosyl)oxy]-2-hydroxy-3-(D-lyxofuranosyloxy)cyclohexyl]-2-hydroxybutanamide disulfate (salt) |
Fórmula molecular |
C21H45N5O20S2 |
Peso Molecular |
751.7335 |
InChI |
InChI=1/C21H41N5O12.2H2O4S/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21;2*1-5(2,3)4/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34);2*(H2,1,2,3,4)/t6?,7?,8?,9?,10-,11+,12-,13?,14+,15-,16+,17?,18-,20?,21?;;/m1../s1 |
Número de registro CAS |
51022-98-1 |
Estructura Molecular |
|
Punto de ebullición |
947.4°C at 760 mmHg |
Punto de inflamación |
526.8°C |
Presión de vapor |
0mmHg at 25°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|